Trial intelligence / Profile preview

Dabigatran in Atrial Fibrillation Fibrosis

NCT01546883Phase 4Terminated

Sponsor
University of Utah
Start
Feb 2012
Primary completion
Dec 2013
Countries
1
01

Overview

A Phase 4 trial of dabigatran in Atrial fibrillation (AFib), sponsored by University of Utah. Started Feb 2012; status: terminated.

02

Drugs

dabigatran
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT01546883.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01546883.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call